Modulation of bilirubin neurotoxicity by the Abcb1 transporter in the Ugt1-/- lethal mouse model of neonatal hyperbilirubinemia

Autor: Claudio Tiribelli, Jana Jašprová, Jaroslav Zelenka, Libor Vítek, Luka Bočkor, Andrés F. Muro, Alessandra Iaconcig, Giulia Bortolussi, Simone Vodret
Rok vydání: 2016
Předmět:
0301 basic medicine
Male
Neurotoxicity Syndrome
Bilirubin
Cell Survival
Central nervous system
Brain damage
Biology
Pharmacology
03 medical and health sciences
chemistry.chemical_compound
bilirubin
neurotoxicity syndromes
hyperbilirubinemia
neonatal jaundice
membrane transport proteins
plasma
brain
cerebellum
mice
p-glycoprotein

Mice
0302 clinical medicine
Cerebellum
Genetics
medicine
Animals
Humans
ATP Binding Cassette Transporter
Subfamily B
Member 1

Glucuronosyltransferase
Molecular Biology
hyperbilirubinemia
bilirubin neurotoxicity
Ugt1a1
Abcb1

Genetics (clinical)
Mice
Knockout

Neurotoxicity
General Medicine
Jaundice
medicine.disease
Disease Models
Animal

030104 developmental biology
medicine.anatomical_structure
chemistry
Animals
Newborn

Toxicity
Kernicterus
Female
Neurotoxicity Syndromes
medicine.symptom
Hyperbilirubinemia
Neonatal

Multidrug Resistance-Associated Proteins
030217 neurology & neurosurgery
Zdroj: Human molecular genetics. 26(1)
ISSN: 1460-2083
Popis: Moderate neonatal jaundice is the most common clinical condition during newborn life. However, a combination of factors may result in acute hyperbilirubinemia, placing infants at risk of developing bilirubin encephalopathy and death by kernicterus. While most risk factors are known, the mechanisms acting to reduce susceptibility to bilirubin neurotoxicity remain unclear. The presence of modifier genes modulating the risk of developing bilirubin- induced brain damage is increasingly being recognised. The Abcb1 and Abcc1 members of the ABC family of transporters have been suggested to have an active role in exporting unconjugated bilirubin from the central nervous system into plasma. However, their role in reducing the risk of developing neurological damage and death during neonatal development is still unknown. To this end, we mated Abcb1a/b-/- and Abcc1-/- strains with Ugt1-/- mice, which develop severe neonatal hyperbilirubinemia. While about 60% of Ugt1-/- mice survived after temporary phototherapy, all Abcb1a/b-/-/Ugt1-/- mice died before postnatal day 21, showing higher cerebellar levels of unconjugated bilirubin. Interestingly, Abcc1 role appeared to be less important. In the cerebellum of Ugt1-/- mice, hyperbilirubinemia induced the expression of Car and Pxr nuclear receptors, known regulators of genes involved in the genotoxic response. We demonstrated a critical role of Abcb1 in protecting the cerebellum from bilirubin toxicity during neonatal development, the most clinically relevant phase for human babies, providing further understanding of the mechanisms regulating bilirubin neurotoxicity in vivo. Pharmacological treatments aimed to increase Abcb1 and Abcc1 expression, could represent a therapeutic option to reduce the risk of bilirubin neurotoxicity.
Databáze: OpenAIRE